Hi-Clearance Inc. (TPEX:1788)
Taiwan · Delayed Price · Currency is TWD 137.50
0.00 (0.00%)
Oct 31, 2025, 1:30 PM CST
Hi-Clearance Market Cap
Hi-Clearance has a market cap or net worth of 6.12 billion as of October 31, 2025. Its market cap has decreased by -0.36% in one year.
Market Cap
6.12B
Enterprise Value
6.61B
Revenue
4.13B
Ranking
n/a
PE Ratio
18.16
Stock Price
137.50
Market Cap Chart
Since October 18, 2004, Hi-Clearance's market cap has increased from 875.00M to 6.12B, an increase of 599.62%. That is a compound annual growth rate of 9.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 6.12B | -1.43% |
| Dec 31, 2024 | 6.21B | 2.95% |
| Dec 29, 2023 | 6.03B | 3.39% |
| Dec 30, 2022 | 5.84B | -0.35% |
| Dec 30, 2021 | 5.86B | 30.65% |
| Dec 31, 2020 | 4.48B | 18.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |